Workflow
GE HealthCare Technologies (GEHC)
icon
Search documents
Stock Of The Day: Where Will The GE HealthCare Rally End?
Benzinga· 2025-01-08 19:06
GE HealthCare Technologies Inc. GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.But some traders and investors who hold shares may be selling them before they reach the $103 level. This is why it is our Stock of the Day.Successful traders don't guess. They let the market tell them what to do. They identify important price levels to determine where to place their orders.As you can see on the chart, the $94 leve ...
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
Seeking Alpha· 2024-12-19 13:06
Since I last covered GE HealthCare (NASDAQ: GEHC ) in October 2023, its shares have gained nearly 27% as charted below. This upside contrasts with my hold position because while praising its AI-driven strategy and highlighting the value proposal, I had cautionedAs a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading, or informational reasons. For this purpose, I am not a classical equity researcher from the financial sector, but, I come fro ...
GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL
ZACKS· 2024-12-04 18:30
GE HealthCare Technologies Inc. (GEHC) recently announced the 510(k) submission to the FDA for CleaRecon DL, a deep-learning technology. The company is looking to get FDA clearance for the technology designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite.GE HealthCare is committed to assisting physicians in utilizing image guidance technologies to their maximum capacity by removing obstacles ...
GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging
ZACKS· 2024-12-02 17:25
GE HealthCare Technologies Inc. (GEHC) recently unveiled Sonic DL for 3D to further boost the company’s imaging portfolio. Sonic DL for 3D builds on GE HealthCare’s deep learning innovation legacy and the success of AIR Recon DL.By extending Sonic DL to 3D volumetric imaging, GE HealthCare is likely to expand its use beyond cardiac assessments to include brain, spine, orthopedic, and body exams. The goal of this expansion is to significantly cut scan times while maintaining the same remarkable 12 times scan ...
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care
ZACKS· 2024-11-29 16:25
GE HealthCare Technologies Inc. (GEHC) announced its collaboration with Melbourne, Australia-based Peter MacCallum Cancer Centre on Monday. The tie-up will enable GEHC to further develop and explore the clinical and research possibilities of its total body positron emission tomography/computed tomography (PET/CT) technology designed with a 128 cm, ultra-high sensitivity detector. In turn, Peter MacCallum Cancer Center is expected to leverage the total body PET/CT technology designed by GE HealthCare for its ...
GEHC Stock May Gain Following the Launch of Pristina Via System
ZACKS· 2024-11-27 16:01
GE HealthCare Technologies Inc. (GEHC) recently unveiled the new Pristina Via mammography system. This system will provide mammography technologists with a suite of advanced tools that balance the demands of diagnostic accuracy and workflows to facilitate more patient-centered breast care.As GEHC continues to evolve its Senographe Pristina platform, Pristina Via brings advanced new features to help minimize repetitive tasks and streamline workflows so that mammography technologists can maintain their focus ...
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
ZACKS· 2024-11-25 15:45
GE HealthCare Technologies Inc. (GEHC) recently announced additional clinical applications of the OEC 3D mobile CBCT C-arm portfolio, which enable precise and efficient imaging during endoscopic bronchoscopy procedures in interventional pulmonology.For routine procedures like neuro-spine and orthopedic trauma, as well as interventional procedures like bronchoscopy, GE HealthCare's OEC 3D intraoperative mobile CBCT continues to show imaging superiority and versatility.Likely Trend of GEHC Stock Following the ...
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
GlobeNewswire News Room· 2024-11-21 13:28
DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI Chest Coil to now include GE HealthCare 3 Tesla (3T) MRI scanners for the visualization of Xenon-129 nuclei. With this new introduction, the Compa ...
GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
ZACKS· 2024-11-21 12:36
GE HealthCare Technologies Inc. (GEHC) recently announced the publication of positive data from the two-phase COSMOS (Continuous Ward Monitoring with the GE HealthCare Portrait Mobile Monitoring Solution) pilot study conducted with Cleveland Clinic.The study demonstrated that real-time alerts from Portrait Mobile reduce the duration and severity of vital sign abnormalities. Continuous vital sign monitoring with Portrait Mobile enhances clinical decision-making, reduces alarm fatigue and improves patient out ...
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
ZACKS· 2024-11-14 17:10
GE HealthCare Technologies (GEHC) recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.This new innovative system has the potential to help detect neurological, oncological and psychiatric conditions by providing new clinical imaging and neuroscience capabilities. With SIGNA MAGNUS, GEHC is likely to provide neuroradiologists and neuroscience researchers with a tool that supports advanced imaging and biomarker resea ...